{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-080812","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.347313+00:00","generated_at":"2026-05-31T02:17:19.192052+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oramed & Scilex amend note: $2M prepayment, warrant exercise, liquidity waiver","bullets":["Scilex pays Oramed $2M Sept 23: $1.7M to March 2025 amort, $300K buys back 4M $11.50 warrants.","Oramed can immediately exercise CS-5 Warrant for up to 1,062,500 Scilex shares; remaining half exercisable on original date.","Minimum Liquidity covenant under Note reduced to $0 from Sept 19, 2024 until Maturity (March 21, 2025).","$20M amortization payment due Sept 23, 2024 extended to Sept 30, 2024 without default."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-080812","json":"https://secwatch.observer/filing/0001213900-24-080812.json","markdown":"https://secwatch.observer/filing/0001213900-24-080812.md","text":"https://secwatch.observer/filing/0001213900-24-080812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024080812/0001213900-24-080812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024080812/ea0215344-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:17:19.192052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}